tsukiko.kurokawa@metagentx.com (Yamagata, Japan, June 26, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara), a company focusing on drug discovery and development of intestinal microbiome-based therapeutics for various diseases, will have its Chief Scientific Officer Jun Terauchi and Chief Operating Officer Hiroto Tamura as speaker at the 9th Microbiome Movement Drug Development Summit, to be held in Boston, U.S. from July 10 to July 12, 2024.
Microbiome Movement is the world’s largest microbiome conference for accelerating microbial-based drug development. The 9th Microbiome Movement Drug Development Summit focuses on collectively proving clinical efficacy.
■Schedule
DAY2 Friday,12th, July
13:45～14:15 Track A: Novel R&D & Translation to the Clinic
Fireside Chat:「Collectively Unifying Data Generation in Drug Discovery for Accelerated R&D Progress」
Jun Terauchi, Chief Scientific Officer, Metagen Therapeutics
DAY2 Friday,12th, July
13:45～14:15 Track B: Manufacturing Microbiome-Altering Modalities
「Advances and Challenges of Fecal Microbiota Transplantation Starting from Japan」
Hiroto Tamura, Chief Operating Officer, Metagen Therapeutics
For more information, please visit the following website: